Prediabetes: challenges and opportunities

In the world, the number of patients with carbohydrate metabolism disorders is steadily growing. Over the past 10 years, the number of patients with diabetes mellitus in the world has more than doubled. Moreover, there is not only an increase in the number of patients with diabetes mellitus, predomi...

Full description

Bibliographic Details
Main Authors: T. B. Morgunova, I. V. Glinkina, V. V. Fadeev
Format: Article
Language:Russian
Published: Remedium Group LLC 2021-09-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/6352
_version_ 1797841305722683392
author T. B. Morgunova
I. V. Glinkina
V. V. Fadeev
author_facet T. B. Morgunova
I. V. Glinkina
V. V. Fadeev
author_sort T. B. Morgunova
collection DOAJ
description In the world, the number of patients with carbohydrate metabolism disorders is steadily growing. Over the past 10 years, the number of patients with diabetes mellitus in the world has more than doubled. Moreover, there is not only an increase in the number of patients with diabetes mellitus, predominantly type 2 diabetes, but also with prediabetes. The term «prediabetes» means impaired glucose tolerance and impaired fasting glycemia. To date, it is obvious that the development of prediabetes lead not only to the higher risk of diabetes mellitus in the future, but also of cardiovascular diseases. Factors that increase the risk of cardiovascular events in patients with prediabetes includeare the following: insulin resistance, accompanied by arterial hypertension and dyslipidemia, and postprandial hyperglycemia. Therefore, it is very important to timely identify patients from the risk group, diagnose and treat carbohydrate metabolism disorders already at the stage of prediabetes. Also it is very important to identify the patients from the risk group, diagnose and treat carbohydrate metabolism disorders at the stage of prediabetes. Treatment of patients with prediabetes implies, first of all, lifestyle modification (moderate hypocaloric nutrition with predominant restriction of fats and simple carbohydrates and regular physical activity of moderate intensity) in order to reduce weight. If lifestyle changes are ineffective, drug therapy may be prescribed. The article discusses the studies conducted to assess the effectiveness of lifestyle modification, as well as various options for antihyperglycemic therapy (metformin, glucagon-like peptide receptor agonists, alpha-glucosidase inhibitors, orlistat) for the treatment of patients with prediabetes. It also provides data on long-term follow-up of patients with prediabetes who received different treatment options.
first_indexed 2024-04-09T16:28:54Z
format Article
id doaj.art-ae54258652524d2bb362ca0df5a529de
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:28:54Z
publishDate 2021-09-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-ae54258652524d2bb362ca0df5a529de2023-04-23T06:57:12ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902021-09-0101222022710.21518/2079-701X-2021-12-220-2275730Prediabetes: challenges and opportunitiesT. B. Morgunova0I. V. Glinkina1V. V. Fadeev2Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)In the world, the number of patients with carbohydrate metabolism disorders is steadily growing. Over the past 10 years, the number of patients with diabetes mellitus in the world has more than doubled. Moreover, there is not only an increase in the number of patients with diabetes mellitus, predominantly type 2 diabetes, but also with prediabetes. The term «prediabetes» means impaired glucose tolerance and impaired fasting glycemia. To date, it is obvious that the development of prediabetes lead not only to the higher risk of diabetes mellitus in the future, but also of cardiovascular diseases. Factors that increase the risk of cardiovascular events in patients with prediabetes includeare the following: insulin resistance, accompanied by arterial hypertension and dyslipidemia, and postprandial hyperglycemia. Therefore, it is very important to timely identify patients from the risk group, diagnose and treat carbohydrate metabolism disorders already at the stage of prediabetes. Also it is very important to identify the patients from the risk group, diagnose and treat carbohydrate metabolism disorders at the stage of prediabetes. Treatment of patients with prediabetes implies, first of all, lifestyle modification (moderate hypocaloric nutrition with predominant restriction of fats and simple carbohydrates and regular physical activity of moderate intensity) in order to reduce weight. If lifestyle changes are ineffective, drug therapy may be prescribed. The article discusses the studies conducted to assess the effectiveness of lifestyle modification, as well as various options for antihyperglycemic therapy (metformin, glucagon-like peptide receptor agonists, alpha-glucosidase inhibitors, orlistat) for the treatment of patients with prediabetes. It also provides data on long-term follow-up of patients with prediabetes who received different treatment options.https://www.med-sovet.pro/jour/article/view/6352diabetes mellitustreatmentmetforminimpaired glucose toleranceimpaired fasting glycemia
spellingShingle T. B. Morgunova
I. V. Glinkina
V. V. Fadeev
Prediabetes: challenges and opportunities
Медицинский совет
diabetes mellitus
treatment
metformin
impaired glucose tolerance
impaired fasting glycemia
title Prediabetes: challenges and opportunities
title_full Prediabetes: challenges and opportunities
title_fullStr Prediabetes: challenges and opportunities
title_full_unstemmed Prediabetes: challenges and opportunities
title_short Prediabetes: challenges and opportunities
title_sort prediabetes challenges and opportunities
topic diabetes mellitus
treatment
metformin
impaired glucose tolerance
impaired fasting glycemia
url https://www.med-sovet.pro/jour/article/view/6352
work_keys_str_mv AT tbmorgunova prediabeteschallengesandopportunities
AT ivglinkina prediabeteschallengesandopportunities
AT vvfadeev prediabeteschallengesandopportunities